Determinants of hydroxychloroquine blood concentration variations in systemic lupus erythematosus.

M Jallouli 1 L Galicier 2 N Zahr 3 O Aumaître 4 C Francès 5 V Le Guern 1 F Lioté 6 A Smail 7 N Limal 8 L Perard 9 H Desmurs-Clavel 9 D Le Thi Huong 10 B Asli 2 J-E Kahn 11 J Pourrat 12 L Sailler 13 F Ackermann 11 T Papo 14 K Sacré 14 O Fain 15 J Stirnemann 16 P Cacoub 17, 10 G Leroux 10 J Cohen-Bittan 18 J Sellam 15 X Mariette 19 B Blanchet 20 J S Hulot 3 Z Amoura 10 J C Piette 10 N Costedoat-Chalumeau 1 Aurelien Delluc 21, 22, 23
Abstract : Blood concentrations of hydroxychloroquine (HCQ) vary widely among patients with systemic lupus erythematosus (SLE). A pharmacokinetic/pharmacodynamic relationship has been found in different situations, and a very low blood concentration of HCQ is a simple marker of nonadherence to treatment. Therefore, interest in blood HCQ concentration measurement has increased, but little is known about factors that influence blood HCQ concentration variability. This study was undertaken to analyze determinants of blood HCQ concentrations. We conducted a retrospective analysis of patient data, including data from the Plaquenil Lupus Systemic (PLUS) study, to determine the association of epidemiologic, clinical, and biologic factors with blood HCQ concentrations. Data for nonadherent patients (blood HCQ concentration <200 ng/ml) were excluded. To examine homogeneous pharmacologic data, we restricted the analyses of the PLUS data to the 509 SLE patients receiving 400 mg/day. We found no association of ethnicity or smoking with blood HCQ concentrations and no pharmacokinetic drug-drug interaction with antacids or with inhibitors or inducers of cytochrome P450 enzymes. On multivariate analysis, high body mass index (P = 0.008), no treatment with corticosteroids (P = 0.04), increased time between the last tablet intake and measurement of blood HCQ concentrations (P = 0.017), low platelet count (P < 0.001), low neutrophil count (P < 0.001), and high estimated creatinine clearance (P < 0.001) were associated with low blood HCQ concentrations. In 22 SLE patients with chronic renal insufficiency (median serum creatinine clearance 52 ml/minute [range 23-58 ml/minute]) who received 400 mg/day HCQ, the median blood HCQ concentration was significantly higher than that in the 509 patients from the PLUS study (1,338 ng/ml [range 504-2,229 ng/ml] versus 917 ng/ml [range 208-3316 ng/ml]) (P < 0.001). We provide a comprehensive analysis of determinants of blood HCQ concentrations. Because this measurement is increasingly being used, these data might be useful for clinicians.
Type de document :
Article dans une revue
Arthritis & rheumatology, Wiley, 2015, 67 (8), pp.2176-84. 〈10.1002/art.39194〉
Liste complète des métadonnées

http://hal.univ-brest.fr/hal-01272718
Contributeur : Ghislaine Calvez <>
Soumis le : jeudi 11 février 2016 - 12:04:28
Dernière modification le : jeudi 11 janvier 2018 - 06:25:46

Identifiants

Citation

M Jallouli, L Galicier, N Zahr, O Aumaître, C Francès, et al.. Determinants of hydroxychloroquine blood concentration variations in systemic lupus erythematosus.. Arthritis & rheumatology, Wiley, 2015, 67 (8), pp.2176-84. 〈10.1002/art.39194〉. 〈hal-01272718〉

Partager

Métriques

Consultations de la notice

107